Chesnara Plc: Fourth acquisition in two years
12 November 2026
For investors with a keen eye on the healthcare sector, Semler Scientific, Inc. (NASDAQ: SMLR) presents a compelling opportunity. Operating within the medical devices industry, Semler..
Investors exploring opportunities within the healthcare sector might find RxSight, Inc. (RXST) an intriguing candidate, especially given its potential upside of over 30% as indicated by..
Investors with an eye on the healthcare sector might find Cullinan Therapeutics, Inc. (NASDAQ: CGEM) a compelling opportunity, especially given its promising potential for nearly 96%..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a burgeoning player in the biotechnology sector, is poised to capture investor attention with its staggering potential upside of 156.47%. Specializing..
Personalis, Inc. (NASDAQ: PSNL), a notable player in the healthcare sector, specifically in the diagnostics and research industry, is capturing investor attention with its innovative approach..
Keros Therapeutics, Inc. (NASDAQ: KROS) is drawing significant investor attention with its promising pipeline in the biotechnology sector and a striking potential upside of 96.41%. As..
Amylyx Pharmaceuticals, Inc. (AMLX), a company at the forefront of neurodegenerative disease treatment, is capturing investor attention with a potential upside of 57.45%. Headquartered in Cambridge,..
Maze Therapeutics, Inc. (NASDAQ: MAZE) is making waves in the biotechnology sector with a robust market capitalization of $2.18 billion. As a clinical-stage biopharmaceutical company, Maze..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning player in the biotechnology sector, is attracting significant attention from investors due to its innovative approach and promising pipeline...
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is drawing significant attention from investors with its impressive potential upside of 325.25%. As a key player in the biotechnology sector,..
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is drawing significant attention in the biotechnology sector, and for good reasons. With a market capitalization of $3.19 billion, this clinical-stage..
Theravance Biopharma, Inc. (NASDAQ: TBPH) is attracting attention in the biotechnology sector with its strategic focus on developing and commercializing innovative treatments for respiratory and neurological..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is attracting investor attention with its ambitious pipeline and a staggering potential upside of 404.04% based on current..
Oculis Holding AG (NASDAQ: OCS) is capturing the attention of investors with its promising pipeline in the biotechnology sector, especially in ophthalmology. Based in Zug, Switzerland,..
HealthStream, Inc. (NASDAQ: HSTM), a notable player in the Health Information Services industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With..
Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector specializing in diagnostics and research, presents a fascinating case for investors with its substantial..
Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a noteworthy player in the healthcare staffing industry, providing essential talent management services across the United States. Catering to..
Immunome, Inc. (NASDAQ: IMNM), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its innovative approaches in oncology therapeutics and a..
Ardelyx, Inc. (ARDX), a biotechnology firm headquartered in Waltham, Massachusetts, is capturing investor attention with its promising pipeline and compelling stock potential. Operating within the healthcare..
Delcath Systems, Inc. (DCTH) is making waves in the healthcare sector, particularly within the medical device industry, with its innovative approach to cancer treatment. As an..
